Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5748.00 | 5488.75 | 1.0472 | 1.1251 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 5000.00 | 3240.08 | 5595.00 | 5488.75 | 1.0194 | 1.0511 |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5633.00 | 5488.75 | 1.0263 | 1.0694 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 5000.00 | 3240.08 | 5230.00 | 5488.75 | 0.9529 | 0.8770 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 5000.00 | 3240.08 | 5431.00 | 5488.75 | 0.9895 | 0.9724 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 5000.00 | 3240.08 | 5671.00 | 5488.75 | 1.0332 | 1.0878 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 5362.00 | 5488.75 | 0.9769 | 0.9395 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 4 | 5000.00 | 3240.08 | 5367.00 | 5488.75 | 0.9778 | 0.9419 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 5914.00 | 5488.75 | 1.0775 | 1.2062 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 5000.00 | 3240.08 | 5393.00 | 5488.75 | 0.9826 | 0.9543 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 5000.00 | 3240.08 | 5466.00 | 5488.75 | 0.9959 | 0.9891 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 5000.00 | 3240.08 | 5872.00 | 5488.75 | 1.0698 | 1.1856 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 5000.00 | 3240.08 | 5677.00 | 5488.75 | 1.0343 | 1.0907 |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5456.00 | 5488.75 | 0.9940 | 0.9843 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5530.00 | 5488.75 | 1.0075 | 1.0198 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5386.00 | 5488.75 | 0.9813 | 0.9509 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5481.00 | 5488.75 | 0.9986 | 0.9963 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5698.00 | 5488.75 | 1.0381 | 1.1009 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 3377.00 | 5488.75 | 0.6153 | 0.0559 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 5000.00 | 3240.08 | 5703.00 | 5488.75 | 1.0390 | 1.1033 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5649.00 | 5488.75 | 1.0292 | 1.0771 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 5000.00 | 3240.08 | 5821.00 | 5488.75 | 1.0605 | 1.1607 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 5000.00 | 3240.08 | 1972.00 | 5488.75 | 0.3593 | -0.4795 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5594.00 | 5488.75 | 1.0192 | 1.0506 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 5000.00 | 3240.08 | 5630.00 | 5488.75 | 1.0257 | 1.0680 |